Dashboard
Manage Tickers

HALOHALOZYME THERAPEUTICS, INC.

Nasdaq halozyme.com


$ 52.36 $ 0.73 (1.41 %)    

Friday, 28-Jun-2024 15:59:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.74 $ -3.65 (-0.76 %)
DIA $ 391.11 $ -0.45 (-0.11 %)
SPY $ 544.70 $ -2.94 (-0.54 %)
TLT $ 91.77 $ -1.96 (-2.09 %)
GLD $ 215.03 $ 0.04 (0.02 %)
$ 51.63
$ 51.83
$ 0.00 x 0
$ 0.00 x 0
$ 51.29 - $ 52.52
$ 32.83 - $ 53.00
874,950
na
6.65B
$ 1.02
$ 20.87
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-20-2024 12-31-2023 10-K
3 11-06-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 02-21-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 02-23-2021 12-31-2020 10-K
15 11-02-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 02-24-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 02-21-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 02-20-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-11-2015 03-31-2015 10-Q
38 03-02-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-halozyme-therapeutics-maintains-65-price-target
HC Wainwright & Co. Reiterates Buy on Halo...
06/26/2024 16:19:31

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Halozyme Therapeutics (NASDAQ:HALO) with a Buy and maintains $65 ...

benchmark-maintains-buy-on-halozyme-therapeutics-raises-price-target-to-60
Benchmark Maintains Buy on Halozyme Therap...
06/25/2024 12:34:47

Benchmark analyst Robert Wasserman maintains Halozyme Therapeutics (NASDAQ:HALO) with a Buy and raises the price target from...

halozymes-ocrevus-sc-gets-european-approval-for-multiple-sclerosis-treatment
Halozyme's OCREVUS SC Gets European Approv...
06/25/2024 07:11:23

Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme") today announced that Roche received European Commission (EC) mar...

decoding-12-analyst-evaluations-for-halozyme-therapeutics
Decoding 12 Analyst Evaluations For Halozy...
06/24/2024 12:01:23

hc-wainwright--co-reiterates-buy-on-halozyme-therapeutics-maintains-65-price-target
HC Wainwright & Co. Reiterates Buy on Halo...
06/24/2024 10:09:58

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Halozyme Therapeutics (NASDAQ:HALO) with a Buy and maintains $65 ...

novavax-and-agios-pharmaceuticals-were-among-the-10-biggest-mid-cap-gainers-last-week-june-1-june-7-are-these-in-your-portfolio
Novavax And Agios Pharmaceuticals Were Amo...
06/09/2024 18:29:27

Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their ...

this-exxon-mobil-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-friday
This Exxon Mobil Analyst Is No Longer Bull...
06/07/2024 13:30:32

wells-fargo-maintains-overweight-on-halozyme-therapeutics-raises-price-target-to-58
Wells Fargo Maintains Overweight on Halozy...
06/07/2024 12:39:57

Wells Fargo analyst Mohit Bansal maintains Halozyme Therapeutics (NASDAQ:HALO) with a Overweight and raises the price target...

hc-wainwright--co-maintains-buy-on-halozyme-therapeutics-raises-price-target-to-65
HC Wainwright & Co. Maintains Buy on Haloz...
06/07/2024 11:13:35

HC Wainwright & Co. analyst Mitchell Kapoor maintains Halozyme Therapeutics (NASDAQ:HALO) with a Buy and raises the pric...

piper-sandler-downgrades-halozyme-therapeutics-to-neutral-raises-price-target-to-51
Piper Sandler Downgrades Halozyme Therapeu...
06/07/2024 09:20:03

Piper Sandler analyst Joseph Catanzaro downgrades Halozyme Therapeutics (NASDAQ:HALO) from Overweight to Neutral and raises ...

why-g-iii-apparel-shares-are-trading-lower-by-13-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why G-III Apparel Shares Are Trading Lower...
06/06/2024 17:39:18

halozyme-therapeutics-13-on-thursday-whats-going-on
Halozyme Therapeutics +13% On Thursday: Wh...
06/06/2024 16:34:07

Halozyme Therapeutics surges as it raises FY24 guidance, driven by increased revenue projections and a new European patent for ...

jm-smucker-posts-upbeat-earnings-joins-toro-company-united-natural-foods-semtech-and-other-big-stocks-moving-higher-on-thursday
J.M. Smucker Posts Upbeat Earnings, Joins ...
06/06/2024 14:44:41

halozyme-therapeutics-increases-fy24-adj-eps-from-355-390-to-365-405-vs-3730-est-revenue-from-915m-968m-to-935m-1015b-vs-947327m-est
Halozyme Therapeutics Increases FY24 Adj. ...
06/06/2024 12:43:23

halozyme-receives-issuance-of-new-european-patent-for-enhanze-drug-delivery-platform-will-be-validated-in-37-european-countries-and-expires-on-march-6-2029
Halozyme Receives Issuance Of New European...
06/05/2024 20:08:49

Conference Call Scheduled for Thursday, June 6 at 5:30am PT/8:30am ETSAN DIEGO, June 5, 2024 /PRNewswire/ -- Halozyme Therapeut...

a-glimpse-into-the-expert-outlook-on-halozyme-therapeutics-through-8-analysts
A Glimpse Into The Expert Outlook On Haloz...
06/04/2024 12:00:20

hc-wainwright--co-reiterates-buy-on-halozyme-therapeutics-maintains-50-price-target
HC Wainwright & Co. Reiterates Buy on Halo...
06/04/2024 10:28:31

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Halozyme Therapeutics (NASDAQ:HALO) with a Buy and maintains $50 ...

hc-wainwright--co-reiterates-buy-on-halozyme-therapeutics-maintains-50-price-target
HC Wainwright & Co. Reiterates Buy on Halo...
05/22/2024 11:32:26

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Halozyme Therapeutics (NASDAQ:HALO) with a Buy and maintains $50 ...

halozyme-discloses-that-bristol-myers-squibb-received-updated-action-date-from-us-fda-for-subcutaneous-nivolumab-co-formulated-with-enhanze-halozymes-proprietary-recombinant-human-hyaluronidase-enzyme-the-updated-goal-date-is-december-29-2024
Halozyme Discloses That Bristol Myers Squi...
05/21/2024 11:55:38

Halozyme announced that Bristol Myers Squibb was reassigned a Prescription Drug User Fee Act goal date from the U.S. Food and D...

jmp-securities-maintains-market-outperform-on-halozyme-therapeutics-lowers-price-target-to-71
JMP Securities Maintains Market Outperform...
05/08/2024 17:58:25

JMP Securities analyst Jason Butler maintains Halozyme Therapeutics (NASDAQ:HALO) with a Market Outperform and lowers the pr...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)